FDA Not Seeing the Big Picture

I've always somewhat disliked the FDA for its tendency to block potentially life-saving drugs from the marketplace. But that tendency has never really hit close to home for me... until now.

P&G Female Sex-Drive Patch Stirs Safety Concerns

P&G studied about 1,000 women who said they were bothered by low sex drive and, on average, reported three satisfying sexual experiences per month. The number increased to five for women who were treated with Intrinsa, but also rose to four for women given a dummy patch.

"Is an increase in approximately one sexually satisfying encounter a month ... worth the possibility of an increase in breast cancer or coronary artery disease?" asked Dr. Sidney Wolfe, head of Public Citizen's Health Research Group. He urged the FDA panel to reject the drug.

Wolfe isn't seeing the big picture. How large an increase in sexually satisfying encounters did the man experience? And how did that improve the relationship? Huh? Tell me that! I think we all know why these male scientists are trying to develop this patch. They must have this data.

Look for the tongue in the cheek people.